Table 5:
Matched comparison between patients with and without neoadjuvant treatment undergoing pneumonectomy
| Variables | Without neoadjuvant (1312 patients) | With neoadjuvant (1312 patients) | Standardized difference (%) |
|---|---|---|---|
| Age (years), mean (SD) | 60.4 (8.7) | 60.2 (8.4) | 2 |
| Female gender, n (%) | 263 (20) | 295 (23) | −6 |
| BMI (kg/m2), mean (SD) | 25.5 (4.1) | 25.2 (3.9) | 6 |
| ppoFEV1%, mean (SD) | 57.0 (19.4) | 56.9 (19.6) | 1 |
| CAD, n (%) | 78 (5.9) | 80 (6.1) | −1 |
| CVD, n (%) | 33 (2.5) | 31 (2.4) | 1 |
| Diabetes, n (%) | 27 (2.1) | 30 (2.3) | −1 |
| PS >1, n (%) | 117 (8.9) | 120 (9.1) | −1 |
| pT stage >1, n (%) | 1095 (83) | 1094 (83) | 1 |
| pN positive, n (%) | 857 (65) | 895 (68) | −6 |
BMI: body mass index; CAD: coronary artery disease; CVD: cerebrovascular disease; pN: pathological nodal stage; ppoFEV1: predicted postoperative forced expiratory volume in 1 s; PS: performance score; pT: pathological tumour stage.